Skip to main content
FinSpry Logo
FinSpry
VCEL logo
VCEL
(NASDAQ)
Vericel Corporation
$34.14-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Vericel (VCEL) Stock Price & Financial Analysis

Vericel Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$31.28 - $35.20
52-Week High$45.97
52-Week Low$28.95
Open$31.82
Volume1.68M
Average Volume (3M)1.68M
Market Cap1.78B
Shares Outstanding52.07M
P/E Ratio (TTM)102.64
Forward P/E64.39
Price to Sales (P/S)6.14
Price to Book (P/B)4.78
EV/EBITDA56.97
Revenue (TTM)276.26M
Net Income (TTM)16.52M
Free Cash Flow (TTM)12.72M
EPS (TTM)$0.32
Profit Margin5.98%
Operating Margin4.00%
Return on Equity (ROE)4.66%
Debt to Equity0.28
50-Day MA$34.89
200-Day MA$36.34
52-Week Change-24.43%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Vericel

What is the current stock price for VCEL?

As of the latest trading session, VCEL stock trades at $34.14. The 52-week range is $28.95–$45.97, with a day range of $31.28–$35.20.

What is the P/E ratio for VCEL?

Vericel's trailing P/E ratio is 102.6, meaning investors pay $102.6 for every $1 of annual earnings. The forward P/E is 64.4, reflecting analyst expectations for future earnings. Vericel operates in the Healthcare sector.

Does VCEL pay dividends?

Vericel does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VCEL?

Based on 1 analyst, the consensus for VCEL is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of VCEL?

Vericel's market capitalization is $1.78B, classifying it as a small-cap company. Vericel operates in the Healthcare sector within the Biotechnology industry.